HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Issam Raad Selected Research

Central Venous Catheters

1/2018Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections.
1/2018Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients.
10/2017Comparing catheter-related bloodstream infections in pediatric and adult cancer patients.
3/2017Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center.
1/2017Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients".
1/2017A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients.
1/2016A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury.
1/2016Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.
1/2015Biofilm-based central line-associated bloodstream infections.
9/2014The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Issam Raad Research Topics

Disease

65Neoplasms (Cancer)
04/2024 - 01/2002
51Infections
04/2024 - 01/2002
46Sepsis (Septicemia)
12/2021 - 01/2002
29Bacteremia
01/2019 - 01/2002
14Neutropenia
06/2022 - 02/2002
9Hematologic Neoplasms (Hematological Malignancy)
06/2022 - 05/2004
9Mycoses (Diseases, Fungus)
12/2017 - 01/2003
8Bacterial Infections (Bacterial Infection)
12/2023 - 05/2007
8Fever (Fevers)
06/2022 - 01/2003
7Aspergillosis
01/2023 - 12/2004
5Critical Illness (Critically Ill)
01/2015 - 01/2004
4Candidemia
01/2021 - 04/2004
4Leukemia
09/2019 - 03/2003
4Catheter-Related Infections
01/2017 - 02/2002
3Febrile Neutropenia
04/2024 - 12/2021
3Invasive Fungal Infections
01/2023 - 01/2003
3Invasive Pulmonary Aspergillosis
12/2018 - 04/2006
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2017 - 01/2003
2Sinusitis
01/2023 - 01/2003
2Mucormycosis
01/2023 - 01/2022
2Fusariosis
01/2023 - 10/2010
2Diabetes Mellitus
01/2023 - 08/2022
2Coinfection
12/2022 - 01/2015
2Breast Neoplasms (Breast Cancer)
09/2019 - 01/2014
2Hypersensitivity (Allergy)
09/2019 - 08/2004
2Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 12/2009
2Lung Neoplasms (Lung Cancer)
12/2018 - 11/2013
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 01/2015
2Communicable Diseases (Infectious Diseases)
01/2016 - 01/2004
2Inflammation (Inflammations)
05/2014 - 11/2013
2Arthralgia (Joint Pain)
06/2004 - 04/2004
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2004 - 01/2003
1Renal Insufficiency (Renal Failure)
01/2023
1COVID-19
12/2022
1Hypertension (High Blood Pressure)
08/2022
1Nausea
01/2021

Drug/Important Bio-Agent (IBA)

23Anti-Bacterial Agents (Antibiotics)IBA
04/2023 - 02/2002
12ProcalcitoninIBA
12/2022 - 12/2012
12VancomycinFDA LinkGeneric
01/2019 - 02/2002
10Minocycline (Cyclops)FDA LinkGeneric
01/2016 - 02/2002
8SolutionsIBA
01/2017 - 02/2002
7Voriconazole (Vfend)FDA LinkGeneric
01/2023 - 01/2007
7Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2013
7Edetic Acid (EDTA)FDA Link
01/2019 - 02/2002
6posaconazoleFDA Link
01/2021 - 01/2007
6CoagulaseIBA
01/2019 - 10/2009
5Linezolid (Zyvox)FDA Link
07/2018 - 07/2003
5Rifampin (Rifampicin)FDA LinkGeneric
09/2014 - 10/2003
4Fluconazole (Zonal)FDA LinkGeneric
01/2021 - 01/2003
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2017 - 11/2013
4Heparin (Liquaemin)FDA LinkGeneric
01/2017 - 02/2002
3Carbapenems (Carbapenem Antibiotics)IBA
04/2024 - 07/2005
3Anti-Infective Agents (Microbicides)IBA
06/2022 - 02/2010
3AzolesIBA
01/2022 - 01/2011
3DaptomycinFDA Link
01/2019 - 08/2010
3Nitroglycerin (Dynamite)FDA LinkGeneric
01/2017 - 01/2016
3Ethanol (Ethyl Alcohol)IBA
01/2016 - 01/2007
2FluoroquinolonesIBA
04/2023 - 02/2010
2Amphotericin B (Amphotericin)FDA LinkGeneric
01/2023 - 01/2019
2isavuconazoleIBA
01/2023 - 01/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2022 - 04/2004
2Lactic Acid (Lactate)FDA LinkGeneric
12/2021 - 08/2021
2C-Reactive ProteinIBA
08/2021 - 12/2014
2Alkaline PhosphataseIBA
01/2021 - 06/2004
2Glucose (Dextrose)FDA LinkGeneric
09/2019 - 01/2014
2Pregnenolone Carbonitrile (PCN)IBA
09/2019 - 01/2017
2Citric Acid (Citrate)FDA LinkGeneric
01/2019 - 01/2016
2CeftarolineFDA Link
01/2019 - 04/2017
2TabletsIBA
03/2016 - 01/2016
2SuspensionsIBA
03/2016 - 01/2007
2Proteins (Proteins, Gene)FDA Link
01/2015 - 11/2013
2AdrenomedullinIBA
04/2013 - 01/2013
2ChlorhexidineIBA
02/2012 - 02/2007
2SteroidsIBA
01/2011 - 01/2003
2Local Anti-Infective Agents (Antiseptics)IBA
12/2009 - 05/2007
2liposomal amphotericin BFDA Link
05/2006 - 01/2003
2SiliconesIBA
08/2004 - 02/2002
2quinupristin-dalfopristin (Synercid)FDA Link
06/2004 - 04/2004
2Itraconazole (Sporanox)FDA LinkGeneric
02/2004 - 01/2003
1Cefepime (Maxipime)FDA LinkGeneric
04/2024
1taniborbactamIBA
04/2024
1LactamsIBA
04/2024
1tebipenemIBA
12/2023
1eravacyclineIBA
04/2023
1delafloxacinIBA
04/2023
1Cephalosporins (Cephalosporin Antibiotics)IBA
06/2022
1tazobactam drug combination ceftolozaneIBA
06/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2021

Therapy/Procedure

48Catheters
01/2019 - 01/2002
38Therapeutics
01/2023 - 01/2002
25Central Venous Catheters
01/2018 - 01/2002
5Drug Therapy (Chemotherapy)
01/2021 - 04/2004
4Duration of Therapy
01/2021 - 01/2018
3Length of Stay
12/2021 - 02/2005
3Renal Dialysis (Hemodialysis)
01/2019 - 10/2003
3Vascular Access Devices (Arterial Line)
10/2007 - 10/2003
2Stem Cell Transplantation
12/2018 - 03/2003
2Critical Care (Surgical Intensive Care)
10/2013 - 01/2011
2Hematopoietic Stem Cell Transplantation
01/2007 - 10/2006
2Induction Chemotherapy
02/2004 - 01/2003